About Rubicon Formulations
Rubicon Formulations is a Healthcare company based in Andheri (India) founded in 1999. It specializes in the development and manufacturing of pharmaceutical and cosmetic products. It operates on a B2B model. The company has 62 employees. Its Indian entity Rubicon Formulations Private Limited reported revenue of ₹123 Cr. Its focus areas include Pharmaceuticals, Drug Manufacturing and Cosmetic Production.
Company details
Rubicon Formulations specializes in the development and manufacturing of pharmaceutical and cosmetic products, focusing on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and cosmetic production. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
- Headquarters Andheri, India
- Employees 62
- SectorsHealthcare
- Email••••••••
- Website rubiconindia.com
- Legal Name Rubicon Formulations Private Limited
- Date of Incorporation 09 Dec, 1999
- Jurisdiction Aurangabad, Maharashtra, India
- Annual Revenue₹123 Cr
FY 2025 · +29% YoY
- Net Profit₹2.28 Cr
FY 2025 · 2% margin
- EBITDA₹4.38 Cr
FY 2025 · 4% margin
- Employee Count62
Associated legal entities of Rubicon Formulations
Rubicon Formulations operates through Rubicon Formulations Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Rubicon Formulations Private Limited CIN U24200MH1999PTC122999 | Active | 09 Dec 1999 | Aurangabad, Maharashtra | ₹123 Cr | 62 | 4 | View details |
Board of directors of Rubicon Formulations Private Limited (Rubicon Formulations)
Rubicon Formulations Private Limited is the primary company behind Rubicon Formulations. The board of Rubicon Formulations Private Limited currently have 4 directors; the longest-serving is Pradeepkumar Chandrashekar Singh, appointed in 1999.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pradeepkumar Chandrashekar Singh DIN 01143105 | Whole-time director | 09 Dec 1999 | 26 yrs 10 mo | Rubicon Formulations Private Limited |
| Ramswarup Sriram Rajoria DIN 01026037 | Whole-time director | 09 Dec 1999 | 26 yrs 10 mo | Rubicon Formulations Private Limited |
| Simon John Lewis DIN 00329039 | Whole-time director | 20 Sep 2001 | 25 yrs | Rubicon Formulations Private Limited |
| Prabhakar Vishwanath Marla DIN 00329161 | Whole-time director | 20 Sep 2001 | 25 yrs | Rubicon Formulations Private Limited |
Financials of Rubicon Formulations
Figures of Rubicon Formulations Private Limited, the primary company behind Rubicon Formulations, for FY 2025. Revenue was ₹123 Cr (+29% year on year). Net profit was ₹2.28 Cr (2% margin). EBITDA was ₹4.38 Cr (4% margin). Revenue has grown at a compounded annual rate of +13% over three years and +7% over five years.
- ₹123 CrRevenue · FY 2025 · +29% YoY
- ₹2.28 CrNet profit · 2% margin
- ₹4.38 CrEBITDA · 4% margin
- ₹72.4 LakhPaid-up capital
- 62Employees (provident fund records)
- +13%Revenue CAGR, 3 years
- +7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Rubicon Formulations Private Limited are on its company page.
Detailed financial statements for Rubicon Formulations
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Rubicon Formulations (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Rubicon Formulations
Rubicon Formulations was founded in 1999.
Rubicon Formulations is headquartered in Andheri, India. It is registered at Andheri, Maharashtra, India.
Rubicon Formulations has 62 employees.
The primary company behind Rubicon Formulations, Rubicon Formulations Private Limited, reported revenue of ₹123 Cr for FY 2025, up 29% year on year.
Rubicon Formulations specializes in the development and manufacturing of pharmaceutical and cosmetic products, focusing on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and cosmetic production. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Rubicon Formulations operates through Rubicon Formulations Private Limited.
The legal entities of Rubicon Formulations currently have 4 directors, including Pradeepkumar Chandrashekar Singh, Simon John Lewis, Ramswarup Sriram Rajoria and others.